-
1
-
-
0026787125
-
Octreotide treatment of acromegaly. A randomized, multicenter study
-
Ezzat S, Snyder PJ, Young WF, Boyajay LD, Newman C, Klibanski A, Molitch ME, Boyd AE, Sheeler L, Cook DM, Malarkey Wb, Jackson I, Vance ML, Thorner MO, Barkan A, Frohman LA, Melmed S. Octreotide treatment of acromegaly. A randomized, multicenter study. Ann Intern Med 1992;117:711-718.
-
(1992)
Ann. Intern. Med.
, vol.117
, pp. 711-718
-
-
Ezzat, S.1
Snyder, P.J.2
Young, W.F.3
Boyajay, L.D.4
Newman, C.5
Klibanski, A.6
Molitch, M.E.7
Boyd, A.E.8
Sheeler, L.9
Cook, D.M.10
Malarkey, Wb.11
Jackson, I.12
Vance, M.L.13
Thorner, M.O.14
Barkan, A.15
Frohman, L.A.16
Melmed, S.17
-
2
-
-
0036319414
-
Somatostatin analogs in acromegaly
-
Freda PU. Somatostatin analogs in acromegaly. J Clin Endocrinol Metab 2002;87:3013-3018.
-
(2002)
J. Clin. Endocrinol. Metab.
, vol.87
, pp. 3013-3018
-
-
Freda, P.U.1
-
3
-
-
0029111738
-
Safety and efficacy of long term octreotide therapy of acromegaly: Results of a multicenter trial in 103 patients - A clinical research center study
-
Newman CB, Melmed S, Snyder PJ, Young WF, Boyajay LD, Levy R, Stewart WN, Klibanski A, Molitch ME, Gagel RF, Boyd AE, Sheeler L, Cook D, Malarkey Wb, Jackson IMD, Vance ML, Thorner MO, Ho PJ, Jaffe CA, Frohman LA, Kleinberg DL. Safety and efficacy of long term octreotide therapy of acromegaly: Results of a multicenter trial in 103 patients - a clinical research center study. J Clin Endocrinol Metab 1995;80:2768-2775.
-
(1995)
J. Clin. Endocrinol. Metab.
, vol.80
, pp. 2768-2775
-
-
Newman, C.B.1
Melmed, S.2
Snyder, P.J.3
Young, W.F.4
Boyajay, L.D.5
Levy, R.6
Stewart, W.N.7
Klibanski, A.8
Molitch, M.E.9
Gagel, R.F.10
Boyd, A.E.11
Sheeler, L.12
Cook, D.13
Malarkey, Wb.14
Jackson, I.M.D.15
Vance, M.L.16
Thorner, M.O.17
Ho, P.J.18
Jaffe, C.A.19
Frohman, L.A.20
Kleinberg, D.L.21
more..
-
4
-
-
7844232389
-
Octreotide as primary therapy for acromegaly
-
Newman CB, Melmed S, George A, Torigian D, Duhaney M, Snyder P, Young W, Klibanski A, Molitch ME, Gagel R, Sheeler L, Cook D, Malarkey W, Jackson I, Vance ML, Barkan A, Frohman L, Kleinberg DL. Octreotide as primary therapy for acromegaly. J Clin Endocrinol Metab 1998;83:3034-3040.
-
(1998)
J. Clin. Endocrinol. Metab.
, vol.83
, pp. 3034-3040
-
-
Newman, C.B.1
Melmed, S.2
George, A.3
Torigian, D.4
Duhaney, M.5
Snyder, P.6
Young, W.7
Klibanski, A.8
Molitch, M.E.9
Gagel, R.10
Sheeler, L.11
Cook, D.12
Malarkey, W.13
Jackson, I.14
Vance, M.L.15
Barkan, A.16
Frohman, L.17
Kleinberg, D.L.18
-
5
-
-
0023775877
-
Long-lasting lowering of serum growth hormone and prolactin levels by single and repetitive cabergoline administration in dopamine-responsive acromegalic patients
-
Ferrari C, Paracchi A, Romano C, Gerevini G, Boghen M, Barreca A, Fortini P, Dubini A. Long-lasting lowering of serum growth hormone and prolactin levels by single and repetitive cabergoline administration in dopamine-responsive acromegalic patients. Clin Endocrinol (Oxf) 1988;29:467-476.
-
(1988)
Clin. Endocrinol. (Oxf.)
, vol.29
, pp. 467-476
-
-
Ferrari, C.1
Paracchi, A.2
Romano, C.3
Gerevini, G.4
Boghen, M.5
Barreca, A.6
Fortini, P.7
Dubini, A.8
-
7
-
-
0031026529
-
Effect of different dopaminergic agents in the treatment of acromegaly
-
Colao A, Ferone D, Marzullo P, DiSarno A, Cerbone G, Sarnacchiaro F, Cirillo S, Merola B, Lombardi G. Effect of different dopaminergic agents in the treatment of acromegaly. J Clin Endocrinol Metab 1997;82:518-523.
-
(1997)
J. Clin. Endocrinol. Metab.
, vol.82
, pp. 518-523
-
-
Colao, A.1
Ferone, D.2
Marzullo, P.3
DiSarno, A.4
Cerbone, G.5
Sarnacchiaro, F.6
Cirillo, S.7
Merola, B.8
Lombardi, G.9
-
8
-
-
0031436037
-
Use of cabergoline in the long-term treatment of hyperprolactinemic and acromegalic patients
-
Muratori M, Arosio M, Gambino G, Romano C, Biella O, Faglia G. Use of cabergoline in the long-term treatment of hyperprolactinemic and acromegalic patients. J Endocrinol Invest 1997;20:537-546.
-
(1997)
J. Endocrinol. Invest.
, vol.20
, pp. 537-546
-
-
Muratori, M.1
Arosio, M.2
Gambino, G.3
Romano, C.4
Biella, O.5
Faglia, G.6
-
9
-
-
0030740018
-
Cabergoline treatment of acromegaly: A preliminary dose finding study
-
Jackson SN, Fowler J, Howlett TA. Cabergoline treatment of acromegaly: A preliminary dose finding study. Clin Endocrinol (Oxf) 1997;46:745-749.
-
(1997)
Clin. Endocrinol. (Oxf.)
, vol.46
, pp. 745-749
-
-
Jackson, S.N.1
Fowler, J.2
Howlett, T.A.3
-
10
-
-
0031792509
-
Cabergoline in the treatment of acromegaly: A study in 64 patients
-
Abs R, Verhelst J, Maiter D, Van Acker K, Nobels F, Coolens J, Mahler C, Beckers A. Cabergoline in the treatment of acromegaly: A study in 64 patients. J Clin Endocrinol Metab 1998;83:374-378.
-
(1998)
J. Clin. Endocrinol. Metab.
, vol.83
, pp. 374-378
-
-
Abs, R.1
Verhelst, J.2
Maiter, D.3
Van Acker, K.4
Nobels, F.5
Coolens, J.6
Mahler, C.7
Beckers, A.8
-
11
-
-
0031767931
-
Cabergoline in acromegaly: A renewed role for dopamine agonist treatment?
-
Cozzi R, Attanasio R, Barausse M, Dallabonzana D, Orlandi P, Da Re N, Branca V, Oppizzi G, Gelli G. Cabergoline in acromegaly: A renewed role for dopamine agonist treatment? Eur J Endocrinol 1998;139:516-521.
-
(1998)
Eur. J. Endocrinol.
, vol.139
, pp. 516-521
-
-
Cozzi, R.1
Attanasio, R.2
Barausse, M.3
Dallabonzana, D.4
Orlandi, P.5
Da Re, N.6
Branca, V.7
Oppizzi, G.8
Gelli, G.9
-
12
-
-
0030019740
-
High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas
-
St-Jean E, Blain F, Comtois R. High prolactin levels may be missed by immunoradiometric assay in patients with macroprolactinomas. Clin Endocrinol (Oxf) 1996;44:305-309.
-
(1996)
Clin. Endocrinol. (Oxf.)
, vol.44
, pp. 305-309
-
-
St-Jean, E.1
Blain, F.2
Comtois, R.3
-
13
-
-
0031946789
-
Pituitary adenomas secreting large amounts of prolactin may give false low values in immunoradiometric assays
-
Petakov MS, Damjanovic SS, Nikolic-Durovic MM, Dragojlovic ZL, Obradovic S, Gligorovic MS, Simic MZ, Popovic VP. Pituitary adenomas secreting large amounts of prolactin may give false low values in immunoradiometric assays. The hook effect. J Endocrinol Invest 1998;21:184-188.
-
(1998)
The Hook Effect J. Endocrinol. Invest.
, vol.21
, pp. 184-188
-
-
Petakov, M.S.1
Damjanovic, S.S.2
Nikolic-Durovic, M.M.3
Dragojlovic, Z.L.4
Obradovic, S.5
Gligorovic, M.S.6
Simic, M.Z.7
Popovic, V.P.8
-
14
-
-
73049154815
-
The volume of the sella turcica
-
DiChirio G, Nelson KB. The volume of the sella turcica. AJR 1962;87:989-980.
-
(1962)
AJR
, vol.87
, pp. 980-989
-
-
DiChirio, G.1
Nelson, K.B.2
|